Home > National Drug Code (NDC) > Butorphanol Tartrate

Butorphanol Tartrate - 0409-1626-02 - (Butorphanol Tartrate)

Alphabetical Index


Drug Information of Butorphanol Tartrate

Product NDC: 0409-1626
Proprietary Name: Butorphanol Tartrate
Non Proprietary Name: Butorphanol Tartrate
Active Ingredient(s): 2    mg/mL & nbsp;   Butorphanol Tartrate
Administration Route(s): INTRAMUSCULAR; INTRAVENOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Butorphanol Tartrate

Product NDC: 0409-1626
Labeler Name: Hospira, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA074626
Marketing Category: ANDA
Start Marketing Date: 19970123

Package Information of Butorphanol Tartrate

Package NDC: 0409-1626-02
Package Description: 3 CONTAINER in 1 CASE (0409-1626-02) > 10 VIAL, SINGLE-DOSE in 1 CONTAINER > 2 mL in 1 VIAL, SINGLE-DOSE

NDC Information of Butorphanol Tartrate

NDC Code 0409-1626-02
Proprietary Name Butorphanol Tartrate
Package Description 3 CONTAINER in 1 CASE (0409-1626-02) > 10 VIAL, SINGLE-DOSE in 1 CONTAINER > 2 mL in 1 VIAL, SINGLE-DOSE
Product NDC 0409-1626
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Butorphanol Tartrate
Dosage Form Name INJECTION, SOLUTION
Route Name INTRAMUSCULAR; INTRAVENOUS
Start Marketing Date 19970123
Marketing Category Name ANDA
Labeler Name Hospira, Inc.
Substance Name BUTORPHANOL TARTRATE
Strength Number 2
Strength Unit mg/mL
Pharmaceutical Classes Competitive Opioid Antagonists [MoA],Opioid Agonist/Antagonist [EPC],Partial Opioid Agonists [MoA]

Complete Information of Butorphanol Tartrate


General Information